PanAmerican Clinical Research and CAIMED announce the Strategic Alliance of Latin American Clinical Studies Centers and the new Research Center combined in Brownsville, TX.


ATLANTA, April 15, 2020 / PRNewsire / – PanAmerican Clinical Research, which offers clinical trials services, home visits and patient recruitment; today announced a partnership with CAIMED, the leading organization of research centers in Latin America, to offer comprehensive and efficient selection of centers in Latin America and bring research innovation to the Rio Grande Valley, Texas.

The alliance reinforces the offer of both organizations to support clinical research in Latin America. PanAmerican and CAIMED operate 12 clinical trial sites that support the development of studies of diseases affecting Hispanic populations and infectious diseases, including COVID-19.

The clinical trial site in Brownsville, TX is a joint research center of excellence, promoting phase I-IV clinical trials in the Rio Grande Valley. Organizations are coupling CAIMED’s sophisticated research infrastructure with the recruitment, community-oriented and PanAmerican´s decentralized model to serve a large and significant patient population.

“PanAmerican is excited for the association with a renowned and global leading research center in infectious disease and vaccine trials,” said Mitchell Parrish, President and General Counsel of PanAmerican. «This alliance offers a unique opportunity for research in Latin America. It also brings a new research center to the Rio Grande Valley in Texas, a growing area, underrepresented by clinical research.

“As a leading organization that has supported clinical research for more than a decade, CAIMED is proud to work with PanAmerican to support more trials for the development of vaccines and clinical therapies,” said Dr. Humberto Reynales, Executive Director. “Our two organizations offer a strong presence in Latin America for quality and compliance research, and now also in the Rio Grande Valley.”



The Center for Medical Attention and Research (CAIMED) is the most experienced general and infectious disease research organization in Latin America, with nine sites in Colombia, the Dominican Republic and Mexico.

CAIMED is ISO 9001 certified; has MetricsMed®, a completely electronic system that complies with Part 11 of the FDA (Electronic Records, Electronic Signatures – Scope and application) and that has carried out 87 trials with more than 19,000 registered participants. Visit: our clinical studies.


About PanAmerican Clinical Research

PanAmerican’s community-oriented, patient-centered approach offers unprecedented patient recruitment and retention and the highest quality data. With experienced research physicians and home health providers in major cities and resource-limited communities, PanAmerican drives research results while building healthier communities. For more information, visit: